Sun Pharmaceutical Industries is set to acquire a 60% stake in Vivaldis Animal Health from its existing shareholders for ₹143.30 crore. Sun Pharma plans to acquire the remaining 40% in the future.

Acuity Law represented Vivaldis Animal Health and their founder, Kunal Khanna in this transaction.

Vivaldis is engaged in the business of trading, distributing, manufacturing, and marketing of drugs, food supplements and over-the-counter products in the companion animal segment of the animal healthcare industry.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.